Novel therapeutic targets in advanced gastric cancer : the insulin-like growth factor signal transduction pathway
Patients with advanced gastric cancer have limited therapeutic options to which response rates are low. Very few targeted therapies are available. There is an urgent need for novel targeted inhibitors for patients who are either ineligible for the existing targeted therapies or have developed resist...
Main Author: | |
---|---|
Published: |
University of Newcastle upon Tyne
2016
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.722332 |